Does RISANKIZUMAB-RZAA Cause Leukaemia? 63 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Leukaemia have been filed in association with RISANKIZUMAB-RZAA. This represents 0.1% of all adverse event reports for RISANKIZUMAB-RZAA.
63
Reports of Leukaemia with RISANKIZUMAB-RZAA
0.1%
of all RISANKIZUMAB-RZAA reports
5
Deaths
18
Hospitalizations
How Dangerous Is Leukaemia From RISANKIZUMAB-RZAA?
Of the 63 reports, 5 (7.9%) resulted in death, 18 (28.6%) required hospitalization.
Is Leukaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 63 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Leukaemia?
RANITIDINE (1,040)
VENETOCLAX (385)
RUXOLITINIB (321)
IMATINIB (242)
ADALIMUMAB (239)
LENALIDOMIDE (219)
NILOTINIB (176)
CLOZAPINE (156)
METHOTREXATE (142)
ETANERCEPT (139)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Leukaemia Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA